Spruce Biosciences | 4:持股變動聲明-董事 SPIEGELMAN DANIEL K
Spruce Biosciences | 4:持股變動聲明-董事 Ways Kirk
Spruce Biosciences | 4:持股變動聲明-董事 SIMPSON CAMILLA V
Spruce Biosciences | 4:持股變動聲明-董事 Barretto-Ko Percival
Spruce Biosciences | 4:持股變動聲明-高管 GREY MICHAEL G
Spruce Biosciences | 4:持股變動聲明-董事 Muralidhar Bali
Spruce Biosciences | 4:持股變動聲明-董事 Aynechi Tiba
Spruce Biosciences | 8-K:重大事件
Spruce Biosciences | 10-Q:季度報表
Spruce Biosciences | 8-K:Spruce Biosciences公佈2024年第一季度財務業績並提供公司最新情況
Spruce Biosciences | 8-K:重大事件
Spruce Biosciences | SC 13G/A:超過5%持股股東披露文件(修正)-Rosalind Advisors, Inc.(3.67%),Steven Salamon(3.67%)等
Spruce Biosciences | ARS:年度報告
Spruce Biosciences | DEFA14A:其他
Spruce Biosciences | DEF 14A:股東委託書決議
Spruce Biosciences | SC 13D/A:超過5%持股股東披露文件(修正)-Novo Holdings A/S(3.9%)
Spruce Biosciences | SC 13G:超過5%持股股東披露文件-Bradley L. Radoff(6.9%)
Spruce Biosciences | SC 13D/A:超過5%持股股東披露文件(修正)-Novo Holdings A/S(6.4%)
Spruce Biosciences | 4:持股變動聲明-股東 Novo Holdings A/S
Spruce Biosciences | SC 13D/A:超過5%持股股東披露文件(修正)-Novo Holdings A/S(10.9%)
暫無數據